SCHEMBL20156042

SCHEMBL20156042

CCOC(=O)/C(C=N)=C(\COC(C)(C)C)NCc1cc2cccnc2nc1C

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C19 P33261 1/20 0.34
SSTR1 P30872 1/20 0.31
SSTR4 P31391 1/20 0.31
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
HSD17B10 Q99714 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
SUCNR1 Q9BXA5 2/20 0.30
HTT P42858 1/20 0.30
BDKRB1 P46663 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156039 0.82 SUCNR1 (0.38) MAPK1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL20156365 0.75 MAPT (0.39) MAPK1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL20156292 0.72 MAPT (0.39) MAPK1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL20156361 0.68 NQO2 (0.30) ALDH1A1
SCHEMBL12895010 0.66 ALDH1A1 (0.40) KDM4EALDH1A1
SCHEMBL20156300 0.66 KDM4E (0.35) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL21281669 0.64 ELANE (0.35) MAPK1MAPTKDM4EALDH1A1HPGD
SCHEMBL28912380 0.64 TSHR (0.52) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL23912916 0.64 MAPT (0.40) MAPK1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL21281665 0.64 ALDH1A1 (0.41) CYP3A4MAPTCYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538527-B1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-10-13 EP disclosed
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed